| Lipid nanoparticles for improved topical application of drugs for skin diseases M Schäfer-Korting, W Mehnert, HC Korting Advanced drug delivery reviews 59 (6), 427-443, 2007 | 808 | 2007 |
| Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin V Jenning, A Gysler, M Schäfer-Korting, SH Gohla European journal of pharmaceutics and biopharmaceutics 49 (3), 211-218, 2000 | 727 | 2000 |
| Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties V Jenning, M Schäfer-Korting, S Gohla Journal of controlled release 66 (2-3), 115-126, 2000 | 702 | 2000 |
| Human defensins JJ Schneider, A Unholzer, M Schaller, M Schäfer-Korting, HC Korting Journal of molecular medicine 83, 587-595, 2005 | 570 | 2005 |
| Mutschler Arzneimittelwirkungen E Mutschler, G Geisslinger, HK Kroemer, M Schäfer-Korting WVg, stuttgart, 2001 | 441 | 2001 |
| Nanoparticles for skin penetration enhancement–a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles S Küchler, MR Radowski, T Blaschke, M Dathe, J Plendl, R Haag, ... European Journal of Pharmaceutics and Biopharmaceutics 71 (2), 243-250, 2009 | 305 | 2009 |
| t4 workshop report: State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology N Alépée, A Bahinski, M Daneshian, B De Wever, E Fritsche, A Goldberg, ... Altex 31 (4), 441, 2014 | 295 | 2014 |
| Lipid nanoparticles for skin penetration enhancement—correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy SL Borgia, M Regehly, R Sivaramakrishnan, W Mehnert, HC Korting, ... Journal of controlled release 110 (1), 151-163, 2005 | 286 | 2005 |
| Solid lipid nanoparticles as drug carriers for topical glucocorticoids CS Maia, W Mehnert, M Schäfer-Korting International journal of pharmaceutics 196 (2), 165-167, 2000 | 285 | 2000 |
| The use of reconstructed human epidermis for skin absorption testing: results of the validation study M Schäfer-Korting, U Bock, W Diembeck, HJ Düsing, A Gamer, ... Alternatives to Laboratory Animals 36 (2), 161-187, 2008 | 284 | 2008 |
| Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease V Oji, KM Eckl, K Aufenvenne, M Nätebus, T Tarinski, K Ackermann, ... The American Journal of Human Genetics 87 (2), 274-281, 2010 | 270 | 2010 |
| Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects G Weindl, M Schaller, M Schäfer-Korting, HC Korting Skin Pharmacology and physiology 17 (5), 207-213, 2004 | 264 | 2004 |
| Transcriptional activity of potent glucocorticoids: relevance of glucocorticoid receptor isoforms and drug metabolites I Spika, S Hammer, B Kleuser, HC Korting, M Schäfer-Korting Skin Pharmacology and Physiology 16 (3), 143-150, 2003 | 262 | 2003 |
| Drug targeting by solid lipid nanoparticles for dermal use C Santos Maia, W Mehnert, M Schaller, HC Korting, A Gysler, ... Journal of Drug Targeting 10 (6), 489-495, 2002 | 262 | 2002 |
| Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-β-induced cell responses C Xin, S Ren, B Kleuser, S Shabahang, W Eberhardt, H Radeke, ... Journal of Biological Chemistry 279 (34), 35255-35262, 2004 | 219 | 2004 |
| Arzneimittelwirkungen–Lehrbuch der Pharmakologie und Toxikologie E Mutschler, G Geisslinger, HK Kroemer, P Ruth, M Schäfer–Korting Endo-Praxis 24 (03), 29-29, 2008 | 205 | 2008 |
| Glucocorticoid entrapment into lipid carriers—characterisation by parelectric spectroscopy and influence on dermal uptake R Sivaramakrishnan, C Nakamura, W Mehnert, HC Korting, KD Kramer, ... Journal of controlled release 97 (3), 493-502, 2004 | 190 | 2004 |
| Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake J Štecová, W Mehnert, T Blaschke, B Kleuser, R Sivaramakrishnan, ... Pharmaceutical research 24, 991-1000, 2007 | 180 | 2007 |
| 1α, 25-Dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate M Manggau, DS Kim, L Ruwisch, R Vogler, M Schäfer-Korting, B Kleuser, ... Journal of Investigative Dermatology 117 (5), 1241-1249, 2001 | 178 | 2001 |
| The Phenion® full-thickness skin model for percutaneous absorption testing K Ackermann, S Lombardi Borgia, HC Korting, KR Mewes, ... Skin Pharmacology and Physiology 23 (2), 105-112, 2010 | 176 | 2010 |
